International immunopharmacologyHumansSTAT3 Transcription FactorAnimalsB7-H1 AntigenFemale
Curculigoside mediates the STAT3/PD-L1 pathway to inhibit the proliferation, invasion, and immune escape of breast cancer cells.
Yandan Lan, Qiang Gu, Ying Feng
Published: 202510.1016/j.intimp.2025.115668
Abstract
Curculigoside (CUR) exhibits anti-inflammatory and anti-tumor effects in various cancers, but there are no research reports on the its effects and mechanisms on breast cancer. Our purpose was to detect the role of CUR in breast cancer and its underly…
Preview only. Read the full abstract at the source